Virtual Medicinal Product (VMP)
-
Haloperidol 5mg/1ml solution for injection ampoules
Name Details
Current Name
Haloperidol 5mg/1ml solution for injection ampoules
|
Start Date
26-05-2004
|
End Date
|
Previous Name
Haloperidol 5mg/ml injection 1ml ampoules
|
Start Date
17-12-2002
|
End Date
25-05-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05AD01
BNF |
Current BNF
04020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04020100
|
Start Date
02-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36053511000001109 |
29-10-2018 |
|
321452008 |
17-12-2002 |
28-10-2018 |
VMP Ingredients
VMP ingredients table
Haloperidol |
Based on Ingredient Substance |
|
5 mg |
1 ml |
Name
Haloperidol
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Haloperidol
-
VMP
(Current) Haloperidol 5mg/1ml solution for inj...
Virtual Medicinal Product Pack (VMPP) Information